Date | Company | Event | Description | Result |
---|---|---|---|---|
Amicus Therapeutics | NDA FILING | MIGALASTAT, Fabry disease | Failure | |
Akebia Therapeutics | Phase 2 | Vadadustat, Anemia related to chronic kidney disease | Success | |
Aerie Pharmaceuticals | Phase 3 | Rhopressa, Glaucoma & ocular hypertension | Success | |
ADMA Biologics | BLA FILING | RI-002, immune deficiency diseases | Success |